연구업적

연도	2023년	2022년	2021년	2020년	2019년
SCI 논문 발표편수	책임	173편	163편	184편	135편	144편
공동	120편	115편	136편	168편	167편
합계	293편	278편	320편	303편	311편

2901. Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma

Mi-Sook Lee 1 2, Sungbin An 1 2, Ji-Young Song 2, Minjung Sung 2, Kyungsoo Jung 1 2, Eun Sol Chang 1 2, Juyoung Choi 2 3, Doo-Yi Oh 4, Yoon Kyung Jeon 5 6, Hobin Yang 7, Chaithanya Lakshmi 8, Sehhoon Park 9, Joungho Han 10, Se-Hoon Lee 1 9, Yoon-La Choi 1 2 10

Cancer Res Treat. 2022 Oct 14. Link

2900. Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

Sara A Hurvitz 1, Roberto Hegg 2, Wei-Pang Chung 3, Seock-Ah Im 4, William Jacot 5, Vinod Ganju 6, Joanne Wing Yan Chiu 7, Binghe Xu 8, Erika Hamilton 9, Srinivasan Madhusudan 10, Hiroji Iwata 11, Sevilay Altintas 12, Jan-Willem Henning 13, Giuseppe Curigliano 14, José Manuel Perez-Garcia 15, Sung-Bae Kim 16, Vanessa Petry 17, Chiun-Sheng Huang 18, Wei Li 19, Jean-Sebastien Frenel 20, Silvia Antolin 21, Winnie Yeo 22, Giampaolo Bianchini 23, Sherene Loi 24, Junji Tsurutani 25, Anton Egorov 26, Y

Lancet. 2023 Jan 14;401(10371):105-117. Link

2899. Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer: Post hoc analyses from PALOMA-2 and PALOMA-3

Hope S Rugo 1, Seock-Ah Im 2, Anil A Joy 3, Yaroslav Shparyk 4, Janice M Walshe 5, Bethany Sleckman 6, Sherene Loi 7, Kathy Puyana Theall 8, Sindy Kim 9, Xin Huang 10, Eustratios Bananis 11, Reshma Mahtani 12, Richard S Finn 13, Véronique Diéras 14

Breast. 2022 Dec;66:324-331. Link

2898. The Effect of Temperament on the Association Between Pre-treatment Anxiety and Chemotherapy-Related Symptoms in Patients With Breast Cancer

Jung-In Choi 1 2, Sanghyup Jung 3 4, Gyu Han Oh 5, Kyung-Lak Son 6, Kwang-Min Lee 7, Dooyoung Jung 8, Tae-Yong Kim 9 10, Seock-Ah Im 9 10 11, Kyung-Hun Lee 9 10, Min-Sup Shin 4, Bong-Jin Hahm 2 4, Chan-Woo Yeom 12

Psychiatry Investig. 2022 Nov;19(11):949-957. Link

2897. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

C E Geyer Jr 1, J E Garber 2, R D Gelber 3, G Yothers 4, M Taboada 5, L Ross 6, P Rastogi 1, K Cui 7, A Arahmani 8, G Aktan 9, A C Armstrong 10, M Arnedos 11, J Balmaña 12, J Bergh 13, J Bliss 14, S Delaloge 15, S M Domchek 16, A Eisen 17, F Elsafy 5, L E Fein 18, A Fielding 7, J M Ford 19, S Friedman 20, K A Gelmon 21, L Gianni 22, M Gnant 23, S J Hollingsworth 24, S-A Im 25, A Jager 26, Ó Þ Jóhannsson 27, S R Lakhani 28, W Janni 29, B Linderholm 30, T-W Liu 31, N Loman 32, L Korde 33, S Loibl

Ann Oncol. 2022 Dec;33(12):1250-1268. Link

2896. Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial

Hope S Rugo 1, Seock-Ah Im 2, Fatima Cardoso 3, Javier Cortes 4 5, Giuseppe Curigliano 6, Antonino Musolino 7 8 9, Mark D Pegram 10, Thomas Bachelot 11, Gail S Wright 12, Cristina Saura 13, Santiago Escrivá-de-Romaní 13, Michelino De Laurentiis 14, Gary N Schwartz 15, Timothy J Pluard 16, Francesco Ricci 17, William R Gwin 3rd 18, Christelle Levy 19, Ursa Brown-Glaberman 20, Jean-Marc Ferrero 21, Maaike de Boer 22, Sung-Bae Kim 23, Katarína Petráková 24, Denise A Yardley 25, Orit Freedman 26, Er

J Clin Oncol. 2023 Jan 10;41(2):198-205. doi: 10.1200/JCO.21.02937. Epub 2022 Nov 4. Link

2895. Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer

Javier Cortes 1, Hope S Rugo 1, David W Cescon 1, Seock-Ah Im 1, Mastura M Yusof 1, Carlos Gallardo 1, Oleg Lipatov 1, Carlos H Barrios 1, Jose Perez-Garcia 1, Hiroji Iwata 1, Norikazu Masuda 1, Marco Torregroza Otero 1, Erhan Gokmen 1, Sherene Loi 1, Zifang Guo 1, Xuan Zhou 1, Vassiliki Karantza 1, Wilbur Pan 1, Peter Schmid 1; KEYNOTE-355 Investigators

N Engl J Med. 2022 Jul 21;387(3):217-226. Link

2894. Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Shanu Modi 1, William Jacot 1, Toshinari Yamashita 1, Joohyuk Sohn 1, Maria Vidal 1, Eriko Tokunaga 1, Junji Tsurutani 1, Naoto T Ueno 1, Aleix Prat 1, Yee Soo Chae 1, Keun Seok Lee 1, Naoki Niikura 1, Yeon Hee Park 1, Binghe Xu 1, Xiaojia Wang 1, Miguel Gil-Gil 1, Wei Li 1, Jean-Yves Pierga 1, Seock-Ah Im 1, Halle C F Moore 1, Hope S Rugo 1, Rinat Yerushalmi 1, Flora Zagouri 1, Andrea Gombos 1, Sung-Bae Kim 1, Qiang Liu 1, Ting Luo 1, Cristina Saura 1, Peter Schmid 1, Tao Sun 1, Dhiraj Gambhire

N Engl J Med. 2022 Jul 7;387(1):9-20. Link

2893. Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study

Massimo Cristofanilli 1, Hope S Rugo 2, Seock-Ah Im 3, Dennis J Slamon 4, Nadia Harbeck 5, Igor Bondarenko 6, Norikazu Masuda 7, Marco Colleoni 8, Angela DeMichele 9, Sherene Loi 10, Hiroji Iwata 11, Ben O'Leary 12, Fabrice André 13, Sibylle Loibl 14, Eustratios Bananis 15, Yuan Liu 16, Xin Huang 16, Sindy Kim 16, Maria Jose Lechuga Frean 16, Nicholas C Turner 12

Clin Cancer Res. 2022 Aug 15;28(16):3433-3442 Link

2892. Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR±HER2- Advanced Breast Cancer in the MONALEESA-3 Trial

Guy Jerusalem 1, Thomas E Delea 2, Migule Martin 3, Michelino De Laurentiis 4, Arnd Nusch 5, J Thaddeus Beck 6, Arlene Chan 7, Seock-Ah Im 8, Patrick Neven 9, Alexander Lonshteyn 2, David Chandiwana 10, Brad Lanoue 10, Peter A Fasching 11

Clin Breast Cancer. 2022 Jun;22(4):326-335. Link

최근 5년 연구업적 현황